Literature DB >> 19389002

The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai, Uganda.

Valerian Kiggundu1, Stephen Watya, Godfrey Kigozi, David Serwadda, Fred Nalugoda, Denis Buwembo, Absolom Settuba, Margaret Anyokorit, James Nkale, Nehemiah Kighoma, Victor Ssempijja, Maria Wawer, Ronald H Gray.   

Abstract

OBJECTIVE: To assess the number of procedures required to achieve optimal competency (time required for surgery with minimal adverse events) in Rakai, Uganda, and thus facilitate the development of guidelines for training providers, as male circumcision reduces the acquisition of human immunodeficiency virus (HIV) in men and is recommended for HIV prevention. PATIENTS AND METHODS: In a randomized trial, 3011 men were circumcised, using the sleeve method, by six physicians who had completed training, which included 15-20 supervised procedures. The duration of surgery from local anaesthesia to wound closure, moderate or severe surgery-related adverse events (AEs), and wound healing were assessed in relation to the number of procedures done by each physician.
RESULTS: The median age of the patients was 24 years. The number of procedures per surgeon was 20-981. The mean time required to complete surgery was approximately 40 min for the first 100 procedures and declined to 25 min for the subsequent 100 circumcisions. After controlling for the number of procedures there was no significant difference in duration of the surgery by patient HIV status or age. The rate of moderate and severe AEs was 8.8% (10/114) for the first 19 unsupervised procedures after training, 4.0% for the next 20-99 (13/328) and 2.0% for the last 100 (P for trend, 0.003). All AEs resolved with management.
CONCLUSION: The completion of more than 100 circumcisions was required before newly trained physicians achieved the optimum duration of surgery. AEs were higher immediately after training and additional supervision is needed for at least the first 20 procedures after completing training.

Entities:  

Mesh:

Year:  2009        PMID: 19389002      PMCID: PMC2748867          DOI: 10.1111/j.1464-410X.2009.08420.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

1.  Male circumcision for HIV prevention: research implications for policy and programming. WHO/UNAIDS technical consultation, 6-8 March 2007. Conclusions and recommendations (excerpts).

Authors: 
Journal:  Reprod Health Matters       Date:  2007-05

2.  Adult male circumcision outcomes: experience in a developing country setting.

Authors:  John N Krieger; Robert C Bailey; John C Opeya; Benard O Ayieko; Felix A Opiyo; Dickens Omondi; Kawango Agot; Corette Parker; J O Ndinya-Achola; Stephen Moses
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

3.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

4.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

5.  Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya.

Authors:  John N Krieger; Robert C Bailey; John Opeya; Benard Ayieko; Felix Opiyo; Kawango Agot; Corette Parker; Jeckoniah O Ndinya-Achola; George A O Magoha; Stephen Moses
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

6.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

7.  Epidemiology of complications of male circumcision in Ibadan, Nigeria.

Authors:  Linus I Okeke; Adanze A Asinobi; Odunayo S Ikuerowo
Journal:  BMC Urol       Date:  2006-08-25       Impact factor: 2.264

8.  The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda.

Authors:  Godfrey Kigozi; Ronald H Gray; Maria J Wawer; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Renee Ridzon; Pius Opendi; Victor Sempijja; Absolom Settuba; Denis Buwembo; Valerian Kiggundu; Margaret Anyokorit; James Nkale; Nehemia Kighoma; Blake Charvat
Journal:  PLoS Med       Date:  2008-06-03       Impact factor: 11.069

  8 in total
  17 in total

1.  Implementation science for the prevention and treatment of HIV/AIDS.

Authors:  Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  Factors associated with the safety of voluntary medical male circumcision in Nyanza province, Kenya.

Authors:  Amy Herman-Roloff; Robert C Bailey; Kawango Agot
Journal:  Bull World Health Organ       Date:  2012-08-27       Impact factor: 9.408

3.  Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision.

Authors:  James M Hotaling; Laura S Leddy; Mahum A Haider; Matthew Mossanen; Michael R Bailey; Brian MacConaghy; Francis Olson; John N Krieger
Journal:  Fertil Steril       Date:  2014-03-06       Impact factor: 7.329

4.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

5.  The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis.

Authors:  Yu Fan; Dehong Cao; Qiang Wei; Zhuang Tang; Ping Tan; Lu Yang; Liangren Liu; Zhenhua Liu; Xiang Li; Wenbin Xue
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

6.  Evaluation of the safety and efficiency of the dorsal slit and sleeve methods of male circumcision provided by physicians and clinical officers in Rakai, Uganda.

Authors:  Dennis Rogers Buwembo; Richard Musoke; Godfrey Kigozi; Victor Ssempijja; David Serwadda; Fredrick Makumbi; Stephen Watya; Dan Namuguzi; Fredrick Nalugoda; Noah Kiwanuka; Nelson K Sewankambo; Fredrick Wabwire-Mangen; Valerian Kiggundu; Maria J Wawer; Ronald H Gray
Journal:  BJU Int       Date:  2011-05-31       Impact factor: 5.588

7.  Building a global health education network for clinical care and research. The benefits and challenges of distance learning tools. Lessons learned from the Hopkins Center for Clinical Global Health Education.

Authors:  Robert C Bollinger; Jane McKenzie-White; Amita Gupta
Journal:  Infect Dis Clin North Am       Date:  2011-06       Impact factor: 5.982

8.  Shang Ring versus forceps-guided adult male circumcision: a randomized, controlled effectiveness study in southwestern Uganda.

Authors:  Samuel Kanyago; David M Riding; Elichum Mutakooha; Alcides Lopez de la O; Mark J Siedner
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

9.  Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.

Authors:  Yira N Alfonso; David Bishai; Agnes Nantongo; Rebecca Kakembo; Sarah Kobusinge; Seema Kacker; Godfrey Kigozi; Ronald Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

10.  Rates of adverse events associated with male circumcision in U.S. medical settings, 2001 to 2010.

Authors:  Charbel El Bcheraoui; Xinjian Zhang; Christopher S Cooper; Charles E Rose; Peter H Kilmarx; Robert T Chen
Journal:  JAMA Pediatr       Date:  2014-07       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.